Follow
Mahmoud Soliman
Mahmoud Soliman
Verified email at ukzn.ac.za - Homepage
Title
Cited by
Cited by
Year
Metal complexes in cancer therapy–an update from drug design perspective
U Ndagi, N Mhlongo, ME Soliman
Drug design, development and therapy, 599-616, 2017
8862017
Theory and applications of covalent docking in drug discovery: merits and pitfalls
HM Kumalo, S Bhakat, MES Soliman
Molecules 20 (2), 1984-2000, 2015
1662015
Recent advancements in the development of anti-tuberculosis drugs
S Chetty, M Ramesh, A Singh-Pillay, MES Soliman
Bioorganic & medicinal chemistry letters 27 (3), 370-386, 2017
1482017
Integrated approach to structure-based enzymatic drug design: molecular modeling, spectroscopy, and experimental bioactivity
B Honarparvar, T Govender, GEM Maguire, MES Soliman, HG Kruger
Chemical reviews 114 (1), 493-537, 2014
1282014
Co-encapsulation of multi-lipids and polymers enhances the performance of vancomycin in lipid–polymer hybrid nanoparticles: In vitro and in silico studies
N Seedat, RS Kalhapure, C Mocktar, S Vepuri, M Jadhav, M Soliman, ...
Materials Science and Engineering: C 61, 616-630, 2016
792016
Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery
P Ramharack, MES Soliman
Journal of Biomolecular Structure and Dynamics 36 (5), 1118-1133, 2018
782018
Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors
B Mathew, A Haridas, G Uçar, I Baysal, AA Adeniyi, MES Soliman, M Joy, ...
International journal of biological macromolecules 91, 680-695, 2016
752016
Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In vitro and rat in vivo studies
GM El-Zaafarany, ME Soliman, S Mansour, GAS Awad
International journal of pharmaceutics 503 (1-2), 127-140, 2016
702016
Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: In vitro and in silico studies
SJ Sonawane, RS Kalhapure, S Rambharose, C Mocktar, SB Vepuri, ...
International journal of pharmaceutics 504 (1-2), 1-10, 2016
672016
Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?
C Agoni, FA Olotu, P Ramharack, ME Soliman
Journal of molecular modeling 26, 1-11, 2020
622020
Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using …
M Lawal, FA Olotu, MES Soliman
Computers in Biology and Medicine 98, 168-177, 2018
612018
An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse transcriptase …
S Bhakat, AJM Martin, MES Soliman
Molecular BioSystems 10 (8), 2215-2228, 2014
592014
Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design
U Ndagi, AA Falaki, M Abdullahi, MM Lawal, ME Soliman
RSC advances 10 (31), 18451-18468, 2020
582020
In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2
M Rudrapal, AR Issahaku, C Agoni, AR Bendale, A Nagar, MES Soliman, ...
Journal of Biomolecular Structure and Dynamics 40 (20), 10437-10453, 2022
552022
The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design
U Ndagi, NN Mhlongo, ME Soliman
Molecular BioSystems 13 (6), 1157-1171, 2017
552017
Covalent versus non-covalent enzyme inhibition: which route should we take? A justification of the good and bad from molecular modelling perspective
A Aljoundi, I Bjij, A El Rashedy, MES Soliman
The protein journal 39 (2), 97-105, 2020
542020
Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones
VN Badavath, S Ciftci-Yabanoglu, S Bhakat, AK Timiri, BN Sinha, G Ucar, ...
Bioorganic chemistry 58, 72-80, 2015
542015
A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses
S Bhakat, W Karubiu, V Jayaprakash, MES Soliman
European journal of medicinal chemistry 87, 677-702, 2014
542014
Quantum mechanics implementation in drug-design workflows: does it really help?
OA Arodola, MES Soliman
Drug design, development and therapy, 2551-2564, 2017
502017
Can we rely on computational predictions to correctly identify ligand binding sites on novel protein drug targets? Assessment of binding site prediction methods and a protocol …
NK Broomhead, ME Soliman
Cell biochemistry and biophysics 75, 15-23, 2017
502017
The system can't perform the operation now. Try again later.
Articles 1–20